Veradigm Pre-Tax Profit Margin 2010-2022 | MDRX
Veradigm pre-tax profit margin from 2010 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Veradigm Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2022-12-31 | $0.59B | $-0.06B | -10.70% |
| 2022-09-30 | $0.60B | $0.12B | 19.70% |
| 2022-06-30 | $0.60B | $0.12B | 20.27% |
| 2022-03-31 | $0.59B | $0.16B | 26.58% |
| 2021-12-31 | $0.58B | $0.16B | 27.16% |
| 2021-09-30 | $-0.14B | $0.12B | -88.57% |
| 2021-06-30 | $0.08B | $0.08B | 97.53% |
| 2021-03-31 | $0.31B | $0.03B | 9.39% |
| 2020-12-31 | $0.56B | $-0.01B | -2.34% |
| 2020-09-30 | $1.43B | $-0.19B | -13.59% |
| 2020-06-30 | $1.51B | $-0.18B | -12.08% |
| 2020-03-31 | $1.58B | $-0.31B | -19.73% |
| 2019-12-31 | $1.63B | $-0.28B | -17.22% |
| 2019-09-30 | $1.63B | $-0.28B | -16.99% |
| 2019-06-30 | $1.62B | $-0.29B | -17.61% |
| 2019-03-31 | $1.62B | $-0.04B | -2.66% |
| 2018-12-31 | $1.62B | $-0.06B | -3.83% |
| 2018-09-30 | $1.52B | $0.03B | 2.18% |
| 2018-06-30 | $1.53B | $0.03B | 1.89% |
| 2018-03-31 | $1.52B | $-0.21B | -13.64% |
| 2017-12-31 | $1.50B | $-0.19B | -12.69% |
| 2017-09-30 | $1.55B | $-0.14B | -8.77% |
| 2017-06-30 | $1.49B | $-0.12B | -8.04% |
| 2017-03-31 | $1.45B | $0.02B | 1.44% |
| 2016-12-31 | $1.39B | $0.03B | 2.31% |
| 2016-09-30 | $1.47B | $0.01B | 0.88% |
| 2016-06-30 | $1.43B | $0.01B | 0.98% |
| 2016-03-31 | $1.40B | $0.02B | 1.07% |
| 2015-12-31 | $1.39B | $0.00B | 0.07% |
| 2015-09-30 | $1.38B | $-0.02B | -1.52% |
| 2015-06-30 | $1.37B | $-0.05B | -3.35% |
| 2015-03-31 | $1.37B | $-0.06B | -4.37% |
| 2014-12-31 | $1.38B | $-0.07B | -4.94% |
| 2014-09-30 | $1.39B | $-0.10B | -6.92% |
| 2014-06-30 | $1.37B | $-0.12B | -8.82% |
| 2014-03-31 | $1.37B | $-0.14B | -10.47% |
| 2013-12-31 | $1.37B | $-0.15B | -10.85% |
| 2013-09-30 | $1.37B | $-0.14B | -10.49% |
| 2013-06-30 | $1.40B | $-0.10B | -7.34% |
| 2013-03-31 | $1.43B | $-0.05B | -3.64% |
| 2012-12-31 | $1.45B | $-0.02B | -1.17% |
| 2012-09-30 | $1.48B | $0.06B | 3.71% |
| 2012-06-30 | $1.49B | $0.10B | 6.46% |
| 2012-03-31 | $1.47B | $0.11B | 7.46% |
| 2011-12-31 | $1.44B | $0.12B | 8.10% |
| 2011-09-30 | $1.37B | $0.08B | 5.76% |
| 2011-06-30 | $1.25B | $0.04B | 3.44% |
| 2011-03-31 | $1.08B | $0.04B | 3.41% |
| 2010-09-30 | $0.62B | $0.05B | 7.78% |
| 2010-06-30 | $0.56B | $0.08B | 15.14% |
| 2010-03-31 | $0.53B | $0.09B | 16.70% |
| 2010-02-28 | $0.51B | $0.08B | 15.18% |
| 2009-09-30 | $0.49B | $0.06B | 13.03% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.498B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.313B | 58.92 |
| Tempus AI (TEM) | United States | $11.516B | 0.00 |
| Doximity (DOCS) | United States | $11.474B | 53.12 |
| Hims & Hers Health (HIMS) | United States | $11.060B | 114.91 |
| IRhythm Technologies (IRTC) | United States | $4.939B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.905B | 61.02 |
| Hinge Health (HNGE) | United States | $3.629B | 0.00 |
| Privia Health (PRVA) | United States | $2.682B | 183.33 |
| Enovis (ENOV) | United States | $1.815B | 10.12 |
| Phreesia (PHR) | United States | $1.695B | 0.00 |
| Schrodinger (SDGR) | United States | $1.512B | 0.00 |
| 10x Genomics (TXG) | United States | $1.444B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.405B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 65.08 |
| Omnicell (OMCL) | United States | $1.376B | 24.28 |
| Evolent Health (EVH) | United States | $1.310B | 111.60 |
| Claritev (CTEV) | United States | $0.716B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.463B | 138.50 |
| Standard BioTools (LAB) | United States | $0.452B | 0.00 |
| TruBridge (TBRG) | United States | $0.349B | 773.33 |
| Outset Medical (OM) | United States | $0.338B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.265B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.167B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.124B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.109B | 0.00 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.89 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.092B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.051B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |